These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 10091152

  • 1. Long-term follow-up of skeletal dysplasia in thalassaemia major.
    Naselli A, Vignolo M, Di Battista E, Garzia P, Forni GL, Traverso T, Aicardi G.
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():817-25. PubMed ID: 10091152
    [Abstract] [Full Text] [Related]

  • 2. Deferoxamine-induced platyspondyly in hypertransfused thalassemic patients.
    Levin TL, Sheth S, Berdon WE, Ruzal-Shapiro C, Piomelli S.
    Pediatr Radiol; 1995 Nov; 25 Suppl 1():S122-4. PubMed ID: 8577502
    [Abstract] [Full Text] [Related]

  • 3. Growth hormone secretion and bone histomorphometric study in thalassaemic patients with acquired skeletal dysplasia secondary to desferrioxamine.
    De Sanctis V, Stea S, Savarino L, Scialpi V, Traina GC, Chiarelli GM, Sprocati M, Govoni R, Pezzoli D, Gamberini R, Rigolin F.
    J Pediatr Endocrinol Metab; 1998 Nov; 11 Suppl 3():827-33. PubMed ID: 10091153
    [Abstract] [Full Text] [Related]

  • 4. Patterns of bone diseases in transfusion-dependent homozygous thalassaemia major: predominance of osteoporosis and desferrioxamine-induced bone dysplasia.
    Chan YL, Pang LM, Chik KW, Cheng JC, Li CK.
    Pediatr Radiol; 2002 Jul; 32(7):492-7. PubMed ID: 12107582
    [Abstract] [Full Text] [Related]

  • 5. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
    Cavallo L, Gurrado R, Zecchino C, Manolo F, De Sanctis V, Cisternino M, Caruso-Nicoletti M, Galati M.
    J Pediatr Endocrinol Metab; 1998 Jul; 11 Suppl 3():845-9. PubMed ID: 10091155
    [Abstract] [Full Text] [Related]

  • 6. Desferrioxamine-induced long bone changes in thalassaemic patients - radiographic features, prevalence and relations with growth.
    Chan YL, Li CK, Pang LM, Chik KW.
    Clin Radiol; 2000 Aug; 55(8):610-4. PubMed ID: 10964732
    [Abstract] [Full Text] [Related]

  • 7. Deferoxamine-induced bone dysplasia in patients with thalassemia major.
    Brill PW, Winchester P, Giardina PJ, Cunningham-Rundles S.
    AJR Am J Roentgenol; 1991 Mar; 156(3):561-5. PubMed ID: 1899759
    [Abstract] [Full Text] [Related]

  • 8. MR imaging of deferoxamine-induced bone dysplasia in an 8-year-old female with thalassemia major.
    Miller TT, Caldwell G, Kaye JJ, Arkin S, Burke S, Brill PW.
    Pediatr Radiol; 1993 Mar; 23(7):523-4. PubMed ID: 8309753
    [Abstract] [Full Text] [Related]

  • 9. Deferoxamine-induced dysplasia of the knee: sonographic features and diagnostic performance compared with magnetic resonance imaging.
    Chan YL, Chu CW, Chik KW, Pang LM, Shing MK, Li CK.
    J Ultrasound Med; 2001 Jul; 20(7):723-8. PubMed ID: 11444730
    [Abstract] [Full Text] [Related]

  • 10. Deferoxamine-induced bone dysplasia in the distal femur and patella of pediatric patients and young adults: MR imaging appearance.
    Chan Y, Li C, Chu WC, Pang L, Cheng JC, Chik KW.
    AJR Am J Roentgenol; 2000 Dec; 175(6):1561-6. PubMed ID: 11090375
    [Abstract] [Full Text] [Related]

  • 11. Short stature and body proportion in thalassaemia.
    Caruso-Nicoletti M, De Sanctis V, Capra M, Cardinale G, Cuccia L, Di Gregorio F, Filosa A, Galati MC, Lauriola A, Malizia R, Mangiagli A, Massolo F, Mastrangelo C, Meo A, Messina MF, Ponzi G, Raiola G, Ruggiero L, Tamborino G, Saviano A.
    J Pediatr Endocrinol Metab; 1998 Dec; 11 Suppl 3():811-6. PubMed ID: 10091151
    [Abstract] [Full Text] [Related]

  • 12. The radiological appearances of thalassaemia.
    Tyler PA, Madani G, Chaudhuri R, Wilson LF, Dick EA.
    Clin Radiol; 2006 Jan; 61(1):40-52. PubMed ID: 16356815
    [Abstract] [Full Text] [Related]

  • 13. Spinal deformities in deferoxamine-treated homozygous beta-thalassemia major patients.
    Hartkamp MJ, Babyn PS, Olivieri F.
    Pediatr Radiol; 1993 Jan; 23(7):525-8. PubMed ID: 8309754
    [Abstract] [Full Text] [Related]

  • 14. Growth and management of short stature in thalassaemia major.
    Theodoridis C, Ladis V, Papatheodorou A, Berdousi H, Palamidou F, Evagelopoulou C, Athanassaki K, Konstantoura O, Kattamis C.
    J Pediatr Endocrinol Metab; 1998 Jan; 11 Suppl 3():835-44. PubMed ID: 10091154
    [Abstract] [Full Text] [Related]

  • 15. Platyspondyly in treated beta-thalassemia.
    Orzincolo C, Castaldi G, Scutellari PN.
    Eur J Radiol; 1994 May; 18(2):129-33. PubMed ID: 8055985
    [Abstract] [Full Text] [Related]

  • 16. Deferoxamine-induced dysplasia-like skeletal abnormalities at radiography and MRI.
    Seif El Dien HM, Esmail RI, Magdy RE, Lotfy HM.
    Pediatr Radiol; 2013 Sep; 43(9):1159-65. PubMed ID: 23563594
    [Abstract] [Full Text] [Related]

  • 17. Spinal involvement in Pyle's disease.
    Turra S, Gigante C, Pavanini G, Bardi C.
    Pediatr Radiol; 2000 Jan; 30(1):25-7. PubMed ID: 10663503
    [Abstract] [Full Text] [Related]

  • 18. [Long-term follow-up and bone imaging in acquired osteochondrodysplasia in a female patient with thalassemia and desferrioxamine hypersensitivity].
    Mangiagli A, De Sanctis V, Campisi S, Di Silvestro G, Urso L.
    Minerva Pediatr; 2000 Apr; 52(4):235-41. PubMed ID: 11995208
    [Abstract] [Full Text] [Related]

  • 19. Growth plate injury of the long bones in treated beta-thalassemia.
    Orzincolo C, Scutellari PN, Castaldi G.
    Skeletal Radiol; 1992 Apr; 21(1):39-44. PubMed ID: 1546335
    [Abstract] [Full Text] [Related]

  • 20. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
    Shalitin S, Carmi D, Weintrob N, Phillip M, Miskin H, Kornreich L, Zilber R, Yaniv I, Tamary H.
    Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.